TALPHERA, INC.

TLPH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Operating Activities
Net Income $-51.5M $-43.2M $-24.4M $-33.4M $-23.4M $-33.4M $-20.1M $-14.3M
Depreciation & Amortization $1.7M $2.1M $2.0M $866.0K $593.0K $605.0K $513.0K $479.0K
Depreciation $1.7M $2.1M $2.0M $900.0K $600.0K
Amortization
Stock-Based Compensation $4.3M $4.5M $5.0M $4.4M $3.5M $2.2M $1.8M $1.4M
Net Cash from Operating Activities $-29.8M $-29.4M $-20.0M $-34.5M $-487.0K $-24.6M $-15.3M $-12.2M
Investing Activities
Capital Expenditures $2.4M $3.7M $1.5M $5.5M $3.3M $826.0K $2.0M $4.0K
Business Acquisitions
Net Cash from Investing Activities $-10.0M $1.8M $8.2M $-6.9M $15.0M $-29.6M $4.8M
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $12.3M $-26.0K $59.6M $47.9M $49.8M $49.6M $3.4M
Net Change in Cash $-27.4M $-27.6M $47.9M $-28.4M $40.5M $40.1M $4.7M $-4.1M
Free Cash Flow $-32.2M $-33.1M $-21.4M $-40.0M $-3.8M $-25.4M $-17.3M $-12.2M
← Newer Page 2 of 3 Older →